Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution.

Högerle BA, Lasitschka F, Muley T, Bougatf N, Herfarth K, Adeberg S, Eichhorn M, Debus J, Winter H, Rieken S, Uhl M.

Radiat Oncol. 2019 Jul 4;14(1):117. doi: 10.1186/s13014-019-1323-z.

2.

Definitive radiotherapy vs. postoperative radiotherapy for lower gingival carcinomas of the mandible : A single-center report about outcome and toxicity.

Lang K, Akbaba S, Held T, Kargus S, Horn D, Bougatf N, Bernhardt D, Freier K, Rieken S, Debus J, Adeberg S.

Strahlenther Onkol. 2019 Jul 2. doi: 10.1007/s00066-019-01484-z. [Epub ahead of print]

PMID:
31267170
3.

Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison.

König L, Bougatf N, Hörner-Rieber J, Chaudhri N, Mielke T, Klüter S, Haefner MF, Rieken S, Haberer T, Debus J, Herfarth K.

Strahlenther Onkol. 2019 Jul;195(7):677-687. doi: 10.1007/s00066-019-01460-7. Epub 2019 Apr 10.

PMID:
30972453
4.

Re-irradiation in locally recurrent lung cancer patients.

Schlampp I, Rieber J, Adeberg S, Bozorgmehr F, Heußel CP, Steins M, Kappes J, Hoffmann H, Welzel T, Debus J, Rieken S.

Strahlenther Onkol. 2019 Apr 1. doi: 10.1007/s00066-019-01457-2. [Epub ahead of print]

PMID:
30937509
5.

Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx.

Akbaba S, Ahmed D, Lang K, Held T, Mattke M, Hoerner-Rieber J, Herfarth K, Rieken S, Plinkert P, Debus J, Adeberg S.

Oral Oncol. 2019 Apr;91:39-46. doi: 10.1016/j.oraloncology.2019.02.019. Epub 2019 Feb 27.

PMID:
30926061
6.

Clinical Management of Blood⁻Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer.

Held T, Akbaba S, Lang K, Harrabi S, Bernhardt D, Freudlsperger C, Kargus S, Plinkert P, Rieken S, Herfarth K, Debus J, Adeberg S.

Cancers (Basel). 2019 Mar 19;11(3). pii: E383. doi: 10.3390/cancers11030383.

7.

Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control.

Akbaba S, Held T, Lang K, Forster T, Federspil P, Herfarth K, Häfner M, Plinkert P, Rieken S, Debus J, Adeberg S.

Cancers (Basel). 2019 Mar 17;11(3). pii: E379. doi: 10.3390/cancers11030379.

8.

Pre-Operative Versus Post-Operative Radiosurgery of Brain Metastases-Volumetric and Dosimetric Impact of Treatment Sequence and Margin Concept.

El Shafie RA, Tonndorf-Martini E, Schmitt D, Weber D, Celik A, Dresel T, Bernhardt D, Lang K, Hoegen P, Adeberg S, Paul A, Debus J, Rieken S.

Cancers (Basel). 2019 Mar 1;11(3). pii: E294. doi: 10.3390/cancers11030294.

9.

Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience.

Akbaba S, Held T, Lang K, Hoerner-Rieber J, Zaoui K, Forster T, Rieken S, Plinkert P, Debus J, Adeberg S.

Radiat Oncol. 2019 Feb 19;14(1):34. doi: 10.1186/s13014-019-1238-8.

10.

Carbon-ion radiotherapy in accelerated hypofractionated active raster-scanning technique for malignant lacrimal gland tumors: feasibility and safety.

Akbaba S, Lang K, Held T, Herfarth K, Rieber J, Plinkert P, Auffarth GU, Rieken S, Debus J, Adeberg S.

Cancer Manag Res. 2019 Feb 1;11:1155-1166. doi: 10.2147/CMAR.S190051. eCollection 2019.

11.

The role of organ- and function-preserving radiotherapy in the treatment of adenoid cystic carcinoma of the larynx.

Akbaba S, Lang K, Bulut OC, Held T, Rieken S, Plinkert P, Jensen A, Herfarth K, Debus J, Adeberg S.

Head Neck. 2019 Jul;41(7):2208-2214. doi: 10.1002/hed.25678. Epub 2019 Feb 5.

PMID:
30723979
12.

Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis.

El Shafie RA, Böhm K, Weber D, Lang K, Schlaich F, Adeberg S, Paul A, Haefner MF, Katayama S, Sterzing F, Hörner-Rieber J, Löw S, Herfarth K, Debus J, Rieken S, Bernhardt D.

Cancer Manag Res. 2019 Jan 17;11:789-801. doi: 10.2147/CMAR.S182154. eCollection 2019.

13.

Palliative Radiotherapy for Leptomeningeal Carcinomatosis-Analysis of Outcome, Prognostic Factors, and Symptom Response.

El Shafie RA, Böhm K, Weber D, Lang K, Schlaich F, Adeberg S, Paul A, Haefner MF, Katayama S, Hörner-Rieber J, Hoegen P, Löw S, Debus J, Rieken S, Bernhardt D.

Front Oncol. 2019 Jan 8;8:641. doi: 10.3389/fonc.2018.00641. eCollection 2018.

14.

Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy.

Bernhardt D, Aufderstrasse S, König L, Adeberg S, Bozorgmehr F, Christopoulos P, Shafie RAE, Hörner-Rieber J, Kappes J, Thomas M, Herth F, Steins M, Debus J, Rieken S.

Cancer Manag Res. 2018 Nov 30;10:6563-6569. doi: 10.2147/CMAR.S180990. eCollection 2018.

15.

Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity.

Lang K, Baur M, Akbaba S, Held T, Kargus S, Bougatf N, Bernhardt D, Freier K, Plinkert PK, Rieken S, Debus J, Adeberg S.

Cancers (Basel). 2018 Dec 4;10(12). pii: E488. doi: 10.3390/cancers10120488.

16.

Advanced Radiation Techniques in the Treatment of Esthesioneuroblastoma: A 7-Year Single-Institution's Clinical Experience.

Liermann J, Syed M, Held T, Bernhardt D, Plinkert P, Jungk C, Unterberg A, Rieken S, Debus J, Herfarth K, Adeberg S.

Cancers (Basel). 2018 Nov 20;10(11). pii: E457. doi: 10.3390/cancers10110457.

17.

Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location.

Adeberg S, Harrabi SB, Bougatf N, Verma V, Windisch P, Bernhardt D, Combs SE, Herfarth K, Debus J, Rieken S.

Cancers (Basel). 2018 Oct 26;10(11). pii: E401. doi: 10.3390/cancers10110401.

18.

Accelerated Hypofractionated Active Raster-Scanned Carbon Ion Radiotherapy (CIRT) for Laryngeal Malignancies: Feasibility and Safety.

Akbaba S, Lang K, Held T, Bulut OC, Mattke M, Uhl M, Jensen A, Plinkert P, Rieken S, Herfarth K, Debus J, Adeberg S.

Cancers (Basel). 2018 Oct 18;10(10). pii: E388. doi: 10.3390/cancers10100388.

19.

Survival and recurrence patterns of multifocal glioblastoma after radiation therapy.

Syed M, Liermann J, Verma V, Bernhardt D, Bougatf N, Paul A, Rieken S, Debus J, Adeberg S.

Cancer Manag Res. 2018 Oct 4;10:4229-4235. doi: 10.2147/CMAR.S165956. eCollection 2018.

20.

Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma.

Haefner MF, Verma V, Bougatf N, Mielke T, Tonndorf-Martini E, König L, Rwigema JM, Simone CB 2nd, Uhlmann L, Eichhorn F, Winter H, Grosch H, Haberer T, Herfarth K, Debus J, Rieken S.

Acta Oncol. 2018 Dec;57(12):1713-1720. doi: 10.1080/0284186X.2018.1502467. Epub 2018 Sep 28.

PMID:
30264630

Supplemental Content

Loading ...
Support Center